OTC: RGBP - Regen BioPharma, Inc.
Доходность за полгода: -22.02%
Сектор: Healthcare
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
5.9 | 27.45 | -78.51% | 119.04 | -95.04% |
P/E Forward 
|
|
4.07 | 119.04 | -96.58% | ||
| P/S |
|
24.89 | 3.19 | 679.68% | 4133.05 | -99.4% |
| P/S Forward |
|
24.89 | 4133.05 | -99.4% | ||
| P/BV |
|
17.56 | 3.41 | 414.44% | -53.15 | -133.04% |
| P/BV Forward |
|
23.01 | -53.15 | -143.3% | ||
| Ev/Ebitda |
|
-7.47 | 12.53 | -159.62% | -199.35 | -96.25% |
| Ev/Ebitda Forward |
|
-7.11 | -199.35 | -96.43% |
